Profile: Wockhardt Ltd (WCKH.BO)

WCKH.BO on Bombay Stock Exchange

760.80INR
12 Feb 2016
Change (% chg)

Rs-114.60 (-13.09%)
Prev Close
Rs875.40
Open
Rs850.00
Day's High
Rs850.00
Day's Low
Rs706.35
Volume
1,237,280
Avg. Vol
216,708
52-wk High
Rs2,000.00
52-wk Low
Rs706.35

Search Stocks
Wockhardt Limited (Wockhardt) is an India-based pharmaceutical and biotechnology company. The Company is focused in biotech research program for the development of diabetes related treatment. It has approximately three research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Clopione, Decdan, Gleedox, H.B Rich, Immumod, Kelo-Cote, Lanagesic, Manix Herbal, Nadimix, Obax, Platin, Rozuone, Sammy, TeMax, Vitix, Wepox and Zedex, among others. It markets insulin and glargine, under the brands Wosulin and Glaritus respectively. It offers Wosulin in the form of a disposable pen, a Wockhardt device. It offers glargine for diabetologists and diabetic patients. Its drug candidates WCK 771, WCK 2349 and WCK 4873 received qualified infectious disease product (QIDP) status in the United States.

Company Address

Wockhardt Ltd

Wockhardt Towers
Bandra Kurla Complex, Bandra (Ea
Bandra (East)
MUMBAI     400051
P: +9122.26534444
F: +9122.26534242

Company Web Links

Search Stocks